Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2024

Clene Inc. (NASDAQ: CLNN) Announces Publication of “Protein Corona Composition of Gold Nanocatalysts” in ACS Pharmacology & Translational Science

Posted on April 2, 2024 by MissionIR

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently reported the … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Upcoming Fourth Quarter Financial Results and Conference Call

Posted on April 1, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, recently announced the scheduled release of its financial results for the fourth quarter and fiscal year 2023, which concluded on December 31, 2023. The release is set … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Turbo Energy S.A. (NASDAQ: TURB) Powering the Future: Tech-Infused Photovoltaics and the Path to Sustainable Energy

Posted on April 1, 2024 by MissionIR

The world is facing a critical juncture. Our dependence on fossil fuels has demonstrably contributed to climate change, necessitating a global shift towards cleaner, more sustainable energy sources. Solar energy, harnessed through photovoltaic (“PV”) technology, offers a promising solution. However, … Continue reading →

Posted in Turbo Energy S.A. TURB | Leave a comment

Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference

Posted on April 1, 2024 by MissionIR

Sigyn Therapeutics (OTCQB: SIGY), a San Diego-headquartered medical technology company that creates medical solutions to treat life-threatening conditions, took part in the recent Emerging Growth Conference, with CEO Jim Joyce giving a live online presentation and updating attendees on the … Continue reading →

Posted in Sigyn Therapeutics Inc. SIGY | Leave a comment